Back to explore
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial
2 Assessments
0 Serious · 1 Some · 1 No · 0 N/A
| Reviewer | Date | Q1.1Does the study have an associated retraction? | Q1.2Does the study have an associated expression of concern or other relevant post-publication notice? | Q1.3Do other studies by the research team highlight causes for concern? | Q2.2Are there concerns relating to the timing or absence of study registration? | Overall | Actions |
|---|---|---|---|---|---|---|---|
| RV017 Evidence Synthesis Methodolodgy Editor | 4 Mar 2026 | No | No | No | No | No concerns | View |
| RV018 Methods Support Unit Manager | 24 Mar 2026 | No | No | Yes | Unclear | Some concerns | View |
Publication Details
Journal
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
30 Dec 2014
Pages
pp. 356–361
ISSN / eISSN
0003-4967